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Summary 
Cholera toxin (CT) has been shown to induce stem cell factor (SCF) production in mouse li- 
gated intestinal loops. Further, SCF interaction(s) with its receptor (c-kit) was shown to be im- 
portant for the intestinal tract secretory response after CT exposure. In this study, we have in- 
vestigated  whether  SCF  production  is  induced  in  the  intestinal  tract  after  exposure  to 
Salmonella typhimurium  and whether this production could be an important intestinal tract re- 
sponse to Salmonella infection. Using a mouse ligated intestinal loop model, increased levels of 
SCF mRNA were detected at 2-4 h post-Salmonella  challenge. Intestinal fluid obtained from 
Salmonella-challenged  loops contained high levels of SCF by ELISA. Human and murine intes- 
tinal epithelial cell lines were also shown to have increased levels ofSCF ml<NA after exposure 
to Salmonella. Inhibition of Salmonella invasion of epithelial cells was shown to be one poten- 
tially important role for SCF:c-kit interactions in host defense to Salmonella infection. Pretreat- 
ment of human or murine intestinal cell lines with SCF resulted in a cellular state that was re- 
sistant to Salmonella invasion. Finally, mice having mutations in the white spotting (W) locus, 
which encodes the SCF-receptor (c-kit), were significantly more susceptible to oral Salmonella 
challenge than their control littermates. Taken together, the above results  suggest that an im- 
portant intestinal tract response to Salmonella infection is an enhanced production of SCF and 
its subsequent interactions with c-kit. 
S 
tem cell factor (SCF), sometimes referred to as mast cell 
growth factor or c-kit ligand (KL) and its receptor, c-kit, 
have been extensively studied and are the subject of many 
recent reviews (1, 2). SCF exists in both membrane-bound 
and  soluble  forms,  with  the  soluble  form representing  a 
cleavage product of a surface bound protein (3, 4).  The 
c-kit protein (CDl17),  the receptor for SCF, is a tyrosine 
kinase-containing receptor of the PDGF/CSF-ItL receptor 
family (5,  6).  SCF:c-kit interactions have been shown to 
play different roles in a wide range of physiological func- 
tions. SCF:c-kit interactions are important for mast devel- 
opment and function (1,  2),  melanocyte development (7, 
8), germ cell development (9,  10),  and may play a role in 
the development and function of the nervous system (11, 
12). Additionally, SCF:c-kit interactions have been shown 
to be important for the enteric nervous system (13--15) and 
for development of TCI<~/8 +  intraepithelial lymphocytes 
(IEL)  (16).  Thus,  SCF:c-kit interactions appear to be im- 
portant  for  certain  aspects  of intestinal  tract  physiology. 
However, the importance of SCF:c-kit interactions in the 
intestinal tract response to infection has not been fully ex- 
plored. Using a mouse ligated intestinal loop model, we have 
recently shown that cholera toxin  (CT)  induces the pro- 
duction of elevated levels of SCF in the intestinal tract, and 
that  SCF:c-kit interactions are  necessary for CT-induced 
intestinal fluid secretion (17). In the present study, we have 
investigated  whether  SCF-production  and/or  SCF:c-kit 
interactions are important intestinal tract responses to Sal- 
monella infection. In this paper, we show the following: (a) 
Salmonella  typhimurium  induces  enhanced  production  of 
SCF in human and mouse intestinal epithelial cell lines and 
in mouse ligated intestinal loops,  (b) pretreating human or 
mouse intestinal cell lines with SCF results in a cellular state 
that  is  resistant  to  Salmonella invasion,  and  (c)  mice  with 
mutations in the white spotting (W) locus, which encodes 
the SCF receptor (c-kit), are more susceptible to oral Sal- 
monella-challenge  than their control littermates. Our results 
suggest  that  SCF  production  and  its  subsequent  interac- 
tion(s) with c-kit may play an important role in the intesti- 
nal tract response to Salmonella infection. 
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Mice.  All mice were purchased  from Jackson Laboratory  (Bar 
Harbor,  ME).  Mice  were  housed  under pathogen-free  condi- 
tions. Female mice at 6-8 wk of age were used from the follow- 
ing mouse strains: WBB6F1/JW/W  v and WBB6F1/J  ++. In some 
experiments, mice were challenged  orally with varying numbers 
of S. typhimurium. LDs0 values were determined by the method of 
Reed and Muench (18). 
Reagents.  Salmonella typhimurium TML-P,,66  were used in all 
experiments.  Cholera toxin (CT) was obtained from List Biologi- 
cal Laboratories,  Inc. (Campbell,  CA). Recombinant rat and hu- 
man SCFs were purified as previously described (19). 
Cell Lines.  The human colonic epithelial cell lines HT-29 and 
T-84 were obtained from the American Type Culture Collection 
(Rockville, MD).  The  human intestinal myofibroblast cell line 
18CO has been previously described  (20) and was a generous gift 
from  Dr.  Don Powell  (UTMB),  The  MODE-K cell  line is  a 
mouse  intestinal epithelial  cell  line which  has  been previously 
characterized  (21) and was obtained from Dr. Dominique Kaiser- 
lian (Unite'd' lmmunologie et  de  Strategie  Vaccinale  Institute 
Pasteur  de  Lyon, Cedex,  France).  All cell lines were  grown in 
Dulbecco's modified Eagle's medium containing 10% heat-inacti- 
vated fetal calf serum, 2 mmol/L  r-gutamine and antibiotics.  In 
some experiments, RNA was obtained from different cell lines at 
varying times post-exposure to  S.  typhimurium.  In these  experi- 
ments, cells were grown to confluency in 75-cm  2 flasks (5 ￿  107 
cells). Cells were grown in antibiotic-free medium and exposed 
to Salmonella (MOI 10:1) for 90 rain. Cells were then washed five 
times  and cultured with medium containing 2￿  antibiotics and 
RNA obtained at varying times post-exposure. 
Northern Blot Analysis.  Human and murine SCF probes have 
been  previously  described  (22,  23).  A  cDNA  probe  for  the 
housekeeping gene  glyceraldehyde-3  phosphate  dehydrogenase 
(G3PDH) was obtained from Clontech Laboratories  (Palo Alto, 
CA).  The  SCF-cDNA  was  nick-translated in  preparation  for 
RNA hybridization. Northern blot analysis was performed as we 
have previously described  (21, 25). Total mucosal RNA or RNA 
from different cell lines was extracted  using guanidine isothiocy- 
anate  and purified by  cesium chloride  gradient centrifugation. 
RNA samples were electrophoresed  through a 1.4% agarose gel 
in the presence  of formaldehyde  then transferred to nylon mem- 
branes.  Filters were UV crosslinked  and baked at  80~  for 2 h 
and prehybridized for 18-24 h  at 42~  in 6x  SSPE,  5;<  Den- 
hardt's solution, 0.5% SDS, 50% formamide, and 300 )xg/ml de- 
natured salmon sperm  DNA.  Hybridization was  performed  at 
42~  for  18-24 h  in 6￿  SSPE, 5X  Denhardt's solution, 0.1% 
SDS, 50% formamide, 100 Ixg/ml denatured salmon sperm DNA 
and 1 X 106 CPM/ml [32p]-DNA. Initial washes were performed 
at room temperature with 5X  SSPE/0.5% SDS for 15 rnin, fol- 
lowed by 15 rain under the same conditions. Filters were then 
washed  twice  in SSPE/0.5% SDS at 42~  for a total of 15 rain. 
Autoradiography  was  performed  with  intensifying screens  at 
-70~  with an exposure  of 1-3 d to XAR-5 film. 
Ligated intestinal loop assay: The ligated loop surgery was per- 
formed  on  mice  as  previously described  (24,  25).  Mice  were 
fasted for 24 h before surgery. A midline abdominal incision was 
made to expose the small intestine, and a single segment ("o5 cm) 
was ligated with 00 silk suture.  Loops were injected with one of 
the  following:  100  Ixl of phosphate-buffered saline  (PBS) only, 
PBS  containing S.  typhimurium  (107 CFU),  or PBS  containing 
cholera toxin (1  Ixg). Incisions were closed with staples and mice 
were sacrificed at varying times post-surgery.  At that time, loops 
were removed, measured,  fluid volume determined, fluid saved 
for SCF-ELISA,  and total RNA isolated as described below. 
Quantitation of Bacteria-infected Cells.  The agarose-agar overlay 
assay was used  to quantitate the number of intestinal epithelial 
cells containing Salmonella.  This assay has  been previously de- 
scribed  (26). Briefly, triplicate  wells of MODE-K cells or 18CO 
cells were treated  overnight with varying concentrations of rSCF 
or medium alone. Before exposure  to Salmonella, cell monolayers 
were maintained in antibiotic-free medium and then exposed  to 
S.  typhimurium  (MOI for MODE-K 1:4, MOI for  18CO  10:1) 
for  1 h.  Noninternalized bacteria  were then counterselected by 
exposing monolayers to medium containing antibiotics for 2 h at 
37~  Monolayers were then extensively washed with antibiotic- 
free  medium and the  number of bacteria-infected cells (CFU/ 
well) determined. 
Mouse SCF ELISA.  An ELISA for quantitating mouse SCF 
was developed using the following reagents: (a) capture  antibody 
was  a rat  monoclonal antibody specific  for  mouse SCF  (JES9- 
28F4) and (b) detecting antibody was a purified and biotinylated 
rabbit IgG specific for mouse SCF (17). Immulon-2 plates (Dy- 
natech Laboratories,  Chantilly, VA) were first coated with 2 p,g/ 
ml of capture  antibody for 24 h at 4~  Wells were then washed 
twice with PBS/Tween-20 and blocked for 2 h with PBS con- 
taining 10% fetal calf serum.  Wells were then washed twice with 
PBS/Tween-20 and ligated loop fluid and varying concentrations 
(10 ng/ml to 100 pg/ml) ofrSCF added to wells for overnight in- 
cubation at 4~  The ELISA was developed by sequential  addi- 
tion of detecting IgG (1  txg/ml)  followed by avidin-peroxidase 
and substrate. Optical densities (405 nm) were next read atier 30-45 
min and SCF  concentrations determined from a  SCF standard 
curve. The SCF-ELISA was sensitive to a level of 400 pg/ml. 
Results  and Discussion 
Salmonella  infection of the gastrointestinal tract results in 
fluid secretion and inflammation. Using a mouse ligated in- 
testinal loop model, we have previously shown that ligated 
intestinal loops  challenged with  S.  typhirnuriurn  have  ele- 
vated levels of nd~NA for ILl, IL6, TNFcx and IFN~/and 
that these  cytokines can be detected in the fluid obtained 
from  such  infected intestinal loops  (24,  25).  The  cellular 
source  for  these  cytokines is  still not  completely under- 
stood. Mast cells represent potentially important sources for 
several of these cytokines and could play an important role 
in the intestinal tract inflammatory response (27). Mast cells 
have been shown capable of producing a number of differ- 
ent cytokines including ILl,  IL6,  TNFo~, and IFN~/  (28). 
Additionally, mast cells are abundant in mucosal tissues and 
have been shown to phagocytize and kill bacteria (29, 30). 
SCF has been shown to be an important mediator of mast 
cell development, mast cell survival, mast cell chemotaxsis, 
and mast cell production of different cytokines (1,  2). Be- 
sides these functions, SCF has also  been shown to  be im- 
portant for  homeostasis  of the  intestinal immune system. 
SCF:c-kit interactions were shown to be required for the 
maintenance and generation of ~/8+ IELs  (16).  Recently, 
we have shown that CT induces enhanced production of 
SCF by the intestinal tract and that SCF:c-kit interaction(s) 
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elevated  levels of SCF mRNA. Ligated intestinal  loops  from C57BL/6 
mice were challenged with one of the following:  (a) PBS (lanes 1 and 2), 
(b) Cholera toxin (1 p.g, lane 3), or (c) S. typhimurium (107 cfu, lanes 4 and 5). 
RNA was obtained  at 2  h  post-challenged.  Each  lane  represents  R.NA 
obtained  from an individual ligated intestinal loop.  Northern blot analysis 
was carried out with a cDNA probe for SCF (A) or for G3PDH (B). 
is  important  for  intestinal  tract  fluid  secretion  induced  by 
CT  (17).  Thus,  we  initiated  experiments  to  investigate 
whether  SCF  production  is  upregulated  in  the  intestinal 
tract  after  S.  typhimurium  infection.  As  seen  in  Fig.  1,  li- 
gated intestinal loops challenged with  Salmonella  contained 
elevated levels of SCF mRNA.  Of the three different sized 
mRNA  transcripts for SCF (6.5-7 kb, 4.5-5 kb, and 3-4 kb) 
the  6.5-kb  transcript  appeared  to be  the  most  dramatically 
enhanced.  CT  also induced increased levels ofSCF  mRNA 
but  at levels significantly lower than  that present in  Salmo- 
nella-challenged  intestinal  loops.  Fluids  obtained  from  in- 
testinal  loops  challenged  with  Salmonella  versus  CT  were 
also  assessed  for  the  presence  of SCF  protein  by  ELISA. 
Fluids  obtained  from  either  Salmonella-  or  CT-challenged 
intestinal  loops  contained  significant levels of SCF protein 
(Fig. 2). 
To explore what cell types might be involved in the en- 
hanced  production  of SCF  after  Salmonella  challenge,  we 
investigated human and mouse intestinal epithelial cell lines 
for  their  ability  to  produce  SCF  after  exposure  to  Salmo- 
nella. As seen in Fig. 3, mouse (MODE-K  cells) and human 
(HT-29  and  18CO)  intestinal  cell lines contained  elevated 
levels ofSCF  mR.NA after exposure to Salmonella.  In these 
cell lines, the 6.5- and 4.5-kb  transcripts  appeared to be the 
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Figure 2.  High levels of SCF are present in the fluid obtained  from li- 
gated intestinal loops challenged with S.  typhimurium. Fluid was obtained 
at  10 h from ligated loops from C57BL/6 mice challenged  with one of 
the following:  (a) PBS,  (b) CT (1  ~g),  or (c) S.  typhimurium (107 CFU). 
The data presented was from fluid obtained from four mice per condition. 
Control loops  (injected with PBS) were gavaged with a volume of PBS 
that was equivalent  to the volumes of fluid contained  in Salmonella-chal- 
lenged loops.  Ligated  intestinal  loops  injected  with  CT  or Salmonella 
yielded roughly equivalent  levels of fluid: Salmonella =  615  +  45 p] per 
loop; CT =  585  +  70 ~1 per loop.  SCF levels are expressed as either ng 
per ml of fluid or ng per loop. 
Figure 3.  Human and murine intestinal epithelial cell fines exposed to 
Salmonella have increased levels of SCF mRNA. Levels of SCF mRNA 
were assessed by  Northern  blot analysis from intestinal  cell lines from 
mouse (MODE-K) and human  (HT-29 and 18CO)  origin as described in 
Materials and Methods  section. RNA was obtained  from MODE-K cells 
exposed to medium only for 4 h (lane 1, control),  or from MODE-K cells 
at the following times post-exposure to S. typhimurium: 30 min (lane 2), 1 h 
(lane 3), 2 h (lane 4) and 4 h (lane 5). RNA was obtained from HT-29 af- 
ter the following treatments: medium only for 1 h (lane I, control),  S. ty- 
phimurium for 30 rain (lane 2),  1 h (lane 3), 2 h (lane 4), and 4 h (lane 5). 
RNA was obtained  from T84 cells after 4 h with medium only (lane  1, 
control)  and after 4 h exposure to S.  typhimurium. Northern blot analysis 
was carried out with a cDNA probe for either mouse or human SCF (A) 
or for G3PDH (B). 
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exposure of the intestinal tract to Salmonella results in an el- 
evated production  of SCF  and  that  one  potential source 
for SCF production is the intestinal fibroblast and/or  epi- 
thelial cell. 
We (31)  and others (32, 33) have previously shown that 
pretreatment  of human  or mouse  epithelial cells or fibro- 
blasts with different cytokines results in a cellular state that 
is resistant to subsequent invasion by Salmonella or other in- 
vasive bacteria.  Since  Salmonella  invasion  induced  an  en- 
hanced production of SCF,  we investigated whether  SCF 
pretreatment offibroblasts or epithelial cells could induce a 
cellular state that is resistant to Salmonella invasion. Cultures 
containing MODE-K  or 18CO  (a human  intestinal fibro- 
blast cell line) were pretreated with varying concentrations 
of rSCF and then assessed for their susceptibility to Salmo- 
nella invasion using a previously described quantitative in- 
vasion assay  (26). As seen  in  Fig.  4,  SCF pretreatment  of 
MODE-K  cells or  18CO  cells resulted  in  a  cellular state 
that was resistant to Salmonella invasion. This effect was de- 
pendent  upon  the  concentration  of SCF,  and  when  high 
concentrations of SCF were  used,  a  80-95%  reduction  in 
Salmonella infected cells was achieved. These results suggest 
that SCF:c-kit interactions may play a rote in host defense 
by inducing a cellular state that does not allow for efficient 
bacterial invasion of epithelial cells and/or fibroblast.s. 
To further explore the possible role of SCF:c-kit interac- 
tions in host defense, we investigated whether WW v mice 
have  alterations in  their resistance to  oral  Salmonella chal- 
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Figure 4.  SCF inhibits Salmone//a  invasion of intestinal cell lines. Trip- 
licate wells of MODE-K cells (A) or 18CO cells (human myofibroblast 
cell line, B) were treated overmght with varying concc.ntrations  of rSCF 
or medium a~ne. Before exposure to  Salmonella,  cell monolaye~ were 
washed in antibiotic-free medium and then  exposed to S.  typhimurium 
(MOI for MODE-K 1:4, MOI for 18CO 10:1) for I h. Nornnterrulized 
bacteria were then counte.z~ected by exposing monolayers to medium 
containing antibiotics for 2 h at 37~  Monolayers were then extensively 
washed with anta'biotic-fi'ee  medium and the number of bacteria-infected 
cells (CFU/weI1) determined using an agarose-agar  overlay assay. 
lenge.  To  investigate  this  possibility, we  determined  the 
LDs0  for  WW v  versus  their  littermate controls  (+ +)  for 
oral challenge with  S.  typhimurium.  Groups of rmce (6 per 
group)  were  given varying doses of Salmonella  (102  to  108 
cfu/mouse)  orally and  then  assessed  daily for  10  d.  The 
LDs0 for WW v mice was  10  s-7, while the LDs0 for their lit- 
termate  controls  was  1075.  Fig.  5  presents  results  from  a 
representative experiment where WW v and their littermate 
controls (+ +) (10 mice per group) were given (orally) 5  ￿ 
106  cfu  of Salmonella and  followed daily for survival.  R,e- 
suits  from  these  experiments  showed  clearly  that  WW v 
mice were  more  susceptible to oral challenge with  Salmo- 
nella. 
Puddington et al. (17) have shown that WW v and S1/S1  a 
mice have a significandy decreased number of"y~ + IEL and 
an increased number of (x[~  +  IEL. This shift in ~/~+ versus 
e([~  + IEL occurred in WW v mice from 6  to  14 wk of age. 
The  mice  used  in  our  studies were  8-14  wk  of age,  and 
therefore  probably  lacked  or  had  significantly  reduced 
numbers  of ~/8"  IEL.  Thus,  a  major question  concerning 
our in vivo results is whether the enhanced susceptibility of 
WW v  mice  to  oral  Salmonella  challenge is due  to  altered 
numbers of~  ~ versus a~+IEL and/or to some other SCF: 
c-kit-dependent function. 
Epithelial cells are now recognized as an important cell 
for regulating both natural and acquired immune functions 
at mucosal surfaces  (34).  An important component  of this 
epithelial cell regulation could ~e .the enhancement of SCF 
and/or  c-kit expression after infection. Enhanced  expres- 
sion of SCF/c-kit by epithelial cells could result in mast cell 
chemotaxis, enhancement of mast cell cytokine production 
and survival, regnalation os  inhibition of bacterial in- 
vasion  of adjacent  epithelial  cells,  and/or  to  some  as  yet 
characterized function(s) that is dependent upon SCF:c-kit 
interactions.  In  summary,  results  presented  in  this  study 
show that an early response of the intestinal tract to Salmo- 
nella infection is the enhanced production of SCF and that 
a potential source of this SCF is the intestinal epithelial cell. 
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Figure  5.  WW v  mice  have  enhanced  susceptibility to  oral  Salmonella 
challenge.  W'W  v  mice  and  their  control  littermates  were  given  an  oral 
dose  of 5  X  106  CFU  of S.  typhiraurium.  10  mice  per group were fol- 
lowed for 12 d  and assessed daily for survival. The difference in cumula- 
tive "mortality between WW v versus + +  control tittermate mice was sta- 
tistically  significant (P <0.001). 
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